Volk Robert J, Linder Suzanne K, Lopez-Olivo Maria A, Kamath Geetanjali R, Reuland Daniel S, Saraykar Smita S, Leal Viola B, Pignone Michael P
Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Division of Rehabilitation Sciences, The University of Texas Medical Branch, Galveston, Texas.
Am J Prev Med. 2016 Nov;51(5):779-791. doi: 10.1016/j.amepre.2016.06.022. Epub 2016 Sep 2.
Decision aids prepare patients to make decisions about healthcare options consistent with their preferences. Helping patients choose among available options for colorectal cancer screening is important because rates are lower than screening for other cancers. This systematic review describes studies evaluating patient decision aids for colorectal cancer screening in average-risk adults and their impact on knowledge, screening intentions, and uptake.
Sources included Ovid MEDLINE, Elsevier EMBASE, EBSCO CINAHL Plus, Ovid PsycINFO through July 21, 2015, pertinent reference lists, and Cochrane review of patient decisions aids. Reviewers independently selected studies that quantitatively evaluated a decision aid compared to one or more conditions or within a pre-post evaluation. Using a standardized form, reviewers independently extracted study characteristics, interventions, comparators, and outcomes. Analysis was conducted in August 2015.
Twenty-three articles representing 21 trials including 11,900 subjects were eligible. Patients exposed to a decision aid showed greater knowledge than those exposed to a control condition (mean difference=18.3 of 100; 95% CI=15.5, 21.1), were more likely to be interested in screening (pooled relative risk=1.5; 95% CI=1.2, 2.0), and more likely to be screened (pooled relative risk=1.3; 95% CI=1.1, 1.4). Decision aid patients had greater knowledge than patients receiving general colorectal cancer screening information (pooled mean difference=19.3 of 100; 95% CI=14.7, 23.8); however, there were no significant differences in screening interest or behavior.
Decision aids improve knowledge and interest in screening, and lead to increased screening over no information, but their impact on screening is similar to general colorectal cancer screening information.
决策辅助工具帮助患者根据自身偏好对医疗保健选项做出决策。帮助患者在结直肠癌筛查的可用选项中进行选择很重要,因为其筛查率低于其他癌症的筛查率。本系统评价描述了评估平均风险成年人结直肠癌筛查患者决策辅助工具及其对知识、筛查意愿和接受度影响的研究。
资料来源包括截至2015年7月21日的Ovid MEDLINE、爱思唯尔EMBASE、EBSCO CINAHL Plus、Ovid PsycINFO、相关参考文献列表以及Cochrane患者决策辅助工具评价。评审人员独立选择与一种或多种对照条件进行比较或在前后评估中对决策辅助工具进行定量评估的研究。评审人员使用标准化表格独立提取研究特征、干预措施、对照和结果。分析于2015年8月进行。
23篇文章代表21项试验,包括11900名受试者,符合入选标准。接触决策辅助工具的患者比接触对照条件的患者知识更丰富(平均差异为100分中的18.3分;95%置信区间=15.5,21.1),对筛查更感兴趣(合并相对风险=1.5;95%置信区间=1.2,2.0),且更有可能接受筛查(合并相对风险=1.3;95%置信区间=1.1,1.4)。使用决策辅助工具的患者比接受一般结直肠癌筛查信息的患者知识更丰富(合并平均差异为100分中的19.3分;95%置信区间=14.7,23.8);然而,在筛查兴趣或行为方面没有显著差异。
决策辅助工具可提高对筛查的知识和兴趣,并导致筛查率高于无信息组,但它们对筛查的影响与一般结直肠癌筛查信息相似。